Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.47 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | BRD2 | P25440 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6852074 | 0.98 | PIK3CD (0.46) | PIK3CDMALT1TSHRKMT2AADRA1B | |
| SCHEMBL7222562 | 0.89 | ADRA1B (0.41) | PIK3CDMALT1TSHRKMT2AADRA1B | |
| SCHEMBL9420505 | 0.89 | MALT1 (0.40) | PIK3CDMALT1TSHRKMT2AADRA1B | |
| SCHEMBL13893014 | 0.89 | PIK3CD (0.50) | PIK3CDTSHRKMT2AADRA1BMEN1 | |
| SCHEMBL15471195 | 0.83 | PIK3CD (0.42) | PIK3CDMALT1TSHRKMT2AADRA1B | |
| SCHEMBL5424673 | 0.82 | PIK3CD (0.54) | PIK3CDMALT1TSHRKMT2AADRA1B | |
| SCHEMBL10264989 | 0.81 | L3MBTL1 (0.45) | PIK3CDTSHRKMT2AMEN1PKM | |
| SCHEMBL22215210 | 0.81 | PIK3CD (0.51) | PIK3CDMALT1TSHRKMT2AADRA1B | |
| SCHEMBL17817660 | 0.80 | CYP1A2 (0.41) | PIK3CDMALT1TSHRKMT2ARAB9A | |
| Hydrochloric Acid SCHEMBL319484 | 0.80 | L3MBTL1 (0.44) | PIK3CDTSHRKMT2AMEN1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 419 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118308040-A | Solar cell and insulating adhesive, battery assembly and photovoltaic system for solar cell | 浙江爱旭太阳能科技有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-106999446-A | Oxapigenin patch | 纽罗德姆有限公司 | 2017-08-01 | — | — | CN | claimed |
| EP-3193849-A1 | OPIPRAMOL PATCH | Neuroderm, Ltd. (IL) | 2017-07-26 | — | — | EP | claimed |
| WO-2016042413-A1 | OPIPRAMOL PATCH | NEURODERM, LTD. (IL) | 2016-03-24 | — | — | WO | claimed |
| US-20120202891-A1 | Cannabinoid-Containing Compositions and Methods for Their Use | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2012-08-09 | — | — | US | claimed |
| EP-1373980-B1 | HIGH PERFORMANCE, PHOTOIMAGEABLE RESIN COMPOSITIONS AND PRINTING PLATES PREPARED THEREFROM | NAPP SYSTEMS INC (US) | 2012-05-09 | — | — | EP | claimed |
| EP-2424568-A1 | CANNABINOID-CONTAINING COMPOSITIONS AND METHODS FOR THEIR USE | University Of Kentucky Research Foundation (US) | 2012-03-07 | — | — | EP | claimed |
| US-7879344-B2 | contains antiitch agent; for use in wipes and absorbent articles, and transdermal patches | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2011-02-01 | — | — | US | claimed |
| WO-2010126501-A1 | CANNABINOID-CONTAINING COMPOSITIONS AND METHODS FOR THEIR USE | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2010-11-04 | — | — | WO | claimed |
| US-20080003273-A1 | Transdermal Delivery of Oleocanthal for Relief of Inflammation | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2008-01-03 | — | — | US | claimed |
| EP-0813879-B1 | Drug administration composition for iontophoresis | HISAMITSU PHARMACEUTICAL CO (JP) | 2002-10-30 | — | — | EP | claimed |
| WO-2002079879-A1 | HIGH PERFORMANCE, PHOTOIMAGEABLE RESIN COMPOSITIONS AND PRINTING PLATES PREPARED THEREFROM | NAPP SYSTEMS, INC. (US) | 2002-10-10 | — | — | WO | claimed |
| US-6127094-A | COMPOSITION COMPRISING CROSSLINKED ACRYLATE COPOLYMER, WASHOUT AID, UNSATURATED MONOMER, PHOTOPOLYMERIZATION INITIATOR, THERMOPLASTIC ELASTOMER, PLASTICIZER, EMULSIFIER | NAPP SYSTEMS INC. (US) | 2000-10-03 | — | — | US | claimed |
| US-5976763-A | COPOLYMER CONTAINING CONJUGATED DIENE, UNSATURATED CARBOXYLIC ACID AND OTHE RUNSATURATED COMPOUNDS | NAPP SYSTEMS, INC. | 1999-11-02 | — | — | US | claimed |
| US-5453166-A | Separation of ethanol from 2-butanone by extractive distillation | Berg, Lloyd (US) | 1995-09-26 | — | — | US | claimed |
| EP-0645438-A2 | Bleed resistance of dyes by counter-ion substitution | Hewlett-Packard Company (US) | 1995-03-29 | — | — | EP | claimed |
| US-5342439-A | Bleed resistance of dyes by counter-ion substitution | HEWLETT-PACKARD CORPORATION (US) | 1994-08-30 | — | — | US | claimed |
| US-5049314-A | N-methylpyrrolidone/2-/ or other lactams | CHUTE CHEMICAL COMPANY (US) | 1991-09-17 | — | — | US | claimed |
| EP-0213245-A1 | High temperature stable aqueous brine fluids viscosified by water-soluble copolymers of acrylamidomethylpropanesulfonic acid salts | MOBIL OIL CORPORATION (US) | 1987-03-11 | — | — | EP | claimed |
| US-4609476-A | DRILLING, WELL COMPLETION | MOBIL OIL CORPORATION (US) | 1986-09-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080003273-A1 | Transdermal Delivery of Oleocanthal for Relief of Inflammation | OXER1, OSBP, OXGR1 | PIK3CD 3163/4885MALT1 361/4885TSHR 4350/4885 |
| US-20120202891-A1 | Cannabinoid-Containing Compositions and Methods for Their Use | CNR2, CNR1, FAAH | PIK3CD 684/4885MALT1 713/4885TSHR 4375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.